Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abrogate, adjuvant, adult, Aid, almonertinib, Ambulatory, ANPRM, AU, Biden, bill, bond, CA, carryback, CECL, Circuit, Colombian, combat, convened, Conversion, CY, cybersecurity, deal, dealing, disincentivize, distancing, electrophilic, Elijah, elongation, enjoined, entertainment, entry, EP, epidemic, EQRx, erlotinib, exemplified, external, Fc, feedback, formulary, gefitinib, HAO, harbor, hear, Hedging, IL, Importantly, incorrect, indefinitely, indirect, insulin, Israeli, Joe, JP, KR, Malaysia, Master, Mexican, MFAR, Modernizing, multicohort, MX, nazartinib, nucleophile, pandemic, paused, payroll, pelabresib, permissible, Pertaining, pharmacy, plc, precautionary, prioritization, project, projected, quarantine, quinazoline, refundable, regulatorily, reimport, reintroduce, Relief, remanded, remotely, running, Samsung, sector, settlement, skin, social, spread, spreading, strain, structure, Subtopic, Surgical, timeline, university, unsatisfactorily, USMCA, Virtual, waiver, worsen, worth, Wuhan, Zenith
Removed:
account, accounted, Acea, amend, American, analytical, attain, attaining, attempted, avitinib, Bio, Cephalon, characterize, clear, commitment, complying, congressional, construction, Corrupt, declining, devoted, differentiate, downturn, educate, epithelial, failing, flexibility, Garrett, geopolitical, Gilead, govern, Gray, heightened, inauguration, inflation, insert, instructing, intensify, IP, line, Mine, mortgage, occurred, oil, PARP, partner, passage, periodically, precipitate, pressure, prodrug, proposing, Qualitative, Quantitative, quicker, ran, regimen, residential, satisfy, select, sparing, spend, Supplementary, Teva, TKI, turmoil, unemployment, unit, Unresolved, viewed, voted, waive
Filing tables
Filing exhibits
Related press release
CKPT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Checkpoint Therapeutics, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statements on Form S3 (No. 333-251005) and Form S-8 (No. 333-216856, No. 333-221488 and No. 333-251000) of Checkpoint Therapeutics, Inc. of our report dated March 12, 2021, relating to the financial statements which appears in this Annual Report on Form 10-K.
| | |
/s/ BDO USA, LLP |
| |
| | |
New York, New York | | |
| | |
March 12, 2021 | | |